Pasar al contenido principal

METALOPROTEINASA-9 Y DEPRESION: ESTUDIO EN UN MODELO ANIMAL Y EN MUESTRAS CEREBRALES HUMANAS POSTMORTEN, Y PAPEL EN EL MECANISMO DE ACCION DE ANTIDEPRESIVOS DE ACCION RAPIDA

RTI2018-097534-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CANTABRIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Antidepressant-like effect and molecular mechanism of action of cannabidiol in the lipopolysaccharide model of depression in mice

  • Florensa-Zanuy, Eva
  • Architravo, Annamaria
  • Adell, Albert
  • Garro-Martínez, Emilio
  • Castro, Elena
  • Díaz, Álvaro
  • Pazos, Ángel
  • Pilar-Cuéllar, Fuencisla
Resumen del trabajo presentado en el 33rd ECNP Congress Virtual, celebrado en modalidad virtual del 12 al 15 de septiembre de 2020., Major Depression is an incapacitating disease spread worldwide. As its etiology is still unknown, some hypotheses have been postulated, being the neuro-inflammatory one of the most recent. The current treatment for depression is far from optimal and there is an urgent need to find fast-acting drugs with fewer side effects. In this regard, cannabidiol (CBD), the major non-psychotropic component of , appears as a promising antidepressant drug. We have evaluated CBD’s behavioural and molecular effects in a neuro-inflammatory model of depression induced by lipopolysaccharide (LPS)., This research was supported by the Ministerio de Economía y Competitividad (SAF2015-67457-R MINECO/FEDER), the Ministerio de Ciencia Innovación y Universidades (RTI2018-097534-B-I00), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM CB/07/09/0029).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Molecular and neurochemical aspects of the antidepressant effects of NLX-101, a selective cortical 5-HT1A receptor biased agonist

  • Cabanu, Sharon
  • Pilar-Cuéllar, Fuencisla
  • Zubakina, Paula
  • Florensa-Zanuy, Eva
  • Senserrich, Júlia
  • Newman-Tancredi, Adrian
  • Adell, Albert
Trabajo presentado en Cell symposia: the biology of neuropsychiatric disorders, celebrada en Sitges (Barcelona) del 15 al 17 de mayo de 2022., Serotonin is considered to be the major neurotransmitter involved in depression and its treatment. Thus, 5-HT receptors have attracted interest as targets for therapeutic intervention. Notably, the activation of presynaptic 5-HT1A autoreceptors slows down the antidepressant effects of serotonin reuptake inhibitors whereas the stimulation of postsynaptic 5-HT1A heteroreceptors is needed for an antidepressant action. NLX-101 exhibits preferential activation of cortical and brain stem 5-HT1A receptors. Here we used behavioral, neurochemical and molecular methods to examine its antidepressant effects. NLX-101 (0.16 mg/kg) reduced immobility in the forced swim test when measured 30 min (albeit not 24 h and 7 days) after drug administration. NLX-101 increased the dialysate dopamine and glutamate in the medial prefrontal cortex, but no changes were observed in the prefrontal output of noradrenaline and serotonin. NLX-101 also produced a rapid increase in the synthesis of pmTOR, pERK1/2 and pGluA1, which may contribute to its rapid antidepressant action., Instituto de Salud Carlos III, FIS grant number Pl19/00170 that was co-funded by the European Regional Development Fund (‘A way to build Europe’), the Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-BI00), and the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (CIBERSAM CB/07/09/0029).